A new medicine for attention-deficit hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-a-day tablet sold under the brand name Simtriyo. It has been approved…
The Conversation Africa
A new ADHD drug targets three brain chemicals instead of two. Here’s what that means
Read full article at The Conversation Africa
Disclaimer: This article summary is sourced from The Conversation Africa. HealthRankings provides this for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
More health news
New York Post
The ‘world’s deadliest animal’ is responsible for killing more than 700,000 people a year
Yesterday
nwitimes.com
FREE TO READ | Free food distribution across the Region in wake of storms
Yesterday
The Washington Post
How 10 minutes of drawing can reset your nervous system
Yesterday
Eatingwell.com